A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
| Κύριος συγγραφέας: | Khan, Muidul Hasan |
|---|---|
| Άλλοι συγγραφείς: | Khair, Nishat Zareen |
| Μορφή: | Thesis |
| Γλώσσα: | English |
| Έκδοση: |
Brac University
2024
|
| Θέματα: | |
| Διαθέσιμο Online: | http://hdl.handle.net/10361/23233 |
Παρόμοια τεκμήρια
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
ανά: Flora, Sanzida Alam
Έκδοση: (2024) -
Detection of acute Lymphocytic Leukemia (ALL) and its type by image processing and machine learning
ανά: Chowdhury, Himadri, κ.ά.
Έκδοση: (2019) -
A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
ανά: Sorno, Rubina Haque
Έκδοση: (2024) -
CAR-T cell Therapy in B-cell Lymphoma
ανά: Faruk, Asef
Έκδοση: (2020) -
A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
ανά: Choki, Kinley
Έκδοση: (2024)